Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.825 USD | -3.40% | -4.35% | +36.09% |
May. 09 | Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Lantern Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.09% | 64.88M | |
+41.12% | 50.93B | |
-0.39% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.13% | 26.02B | |
-22.12% | 18.9B | |
+8.24% | 13.21B | |
+24.21% | 12.17B | |
+30.58% | 12.16B |
- Stock Market
- Equities
- LTRN Stock
- News Lantern Pharma Inc.
- Lantern Pharma Doses First Patient in Phase 1 Trial of Advanced Solid Tumor Drug Candidate